MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

CAMBRIDGE HEALTHTECH INSTITUTE Announces 2nd Annual PROTEIN DISCOVERY TECHNOLOGIES: New Methods and Applications in Therapeutic Development Conference

Release issued 3rd March 2000

Cambridge Healthtech Institute (CHI), a premier provider of biotechnical conferences, is pleased to announce their 2nd Annual PROTEIN DISCOVERY TECHNOLOGIES: New Methods and Applications in Therapeutic Development conference. This meeting, formerly titled Phage Display, will take place April 3-4, 2000 at the Hilton Back Bay in Boston, Massachusetts.

CHI expects to attract over 125 world-class researchers from commercial corporations and academic institutions to this meeting. This is a must attend event for anyone interested in learning about a broad range of applications of phage display and other display methods, including ribosome, yeast, and bacterial surface display. These provide a controlled means of production of peptide and protein libraries that can be used to manufacture and refine molecules for therapeutic development. This includes antibodies, for which there is renewed interest due to the success of therapeutic antibodies currently in the clinic. Therapeutic peptides and proteins offer promise due to the availability of improved delivery methods. There is an increased demand in the use of phage display for the discovery and selection of novel antibiotics, identification of plant pathogens, as well as small molecules for drug development. Display techniques are also being employed in genomics as a tool to generate compounds that affect gene regulation and modification.

Press passes are available for journalists wishing to cover this conference.

For more detailed information, please contact Jennifer Laakso, Marketing Coordinator, Cambridge Healthtech Institute, (617) 630-1385, e-mail jlaakso@healthtech.com

http://www.healthtech.com/conference/00pgd

Company details

If you want to find out more about the company visit Cambridge Healthtech Institute profile.

Latest Cambridge Healthtech Institute press releases

More Press Releases

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us